OOCYTE MATURATION INVOLVES COMPARTMENTALIZATION AND OPPOSING CHANGES OF CAMP LEVELS IN FOLLICULAR SOMATIC AND GERM-CELLS - STUDIES USING SELECTIVE PHOSPHODIESTERASE INHIBITORS
A. Tsafriri et al., OOCYTE MATURATION INVOLVES COMPARTMENTALIZATION AND OPPOSING CHANGES OF CAMP LEVELS IN FOLLICULAR SOMATIC AND GERM-CELLS - STUDIES USING SELECTIVE PHOSPHODIESTERASE INHIBITORS, Developmental biology, 178(2), 1996, pp. 393-402
The second messenger cAMP has been implicated in the regulation of mam
malian and amphibian oocyte maturation. Although a a decrease in intra
oocyte levels of cAMP precedes germinal vesicle breakdown (GVBD), the
gonadotropin induction of ovulation and oocyte maturation is associate
d with major increases of cAMP in ovarian follicles. In the mammalian
system, isolated oocytes undergo spontaneous maturation in vitro but t
his process is blocked by treatment with a phosphodiesterase (PDE) inh
ibitor, IBMX, which increases intraoocyte cAMP levels. In contrast, th
e same inhibitor, when added to cultured follicles for a brief time, i
ncreases follicle cAMP levels, followed by the induction of GVBD. To r
esolve the paradoxical actions of this PDE inhibitor on the maturation
of isolated and follicle-enclosed oocytes, we hypothesized that meiot
ic maturation requires opposing fluctuations of cAMP levels in the som
atic granulosa and germ cells. Such opposing fluctuations may result f
rom selective expression and regulation of PDEs in the somatic and ger
m cell compartments of the follicle. To test this hypothesis, PDE acti
vity was manipulated in different follicular cells using type-specific
inhibitors. The impact of the ensuing changes in cAMP levels in the t
wo compartments was monitored by the induction of GVBD. In isolated oo
cytes, spontaneous GVBD was blocked by two inhibitors of type 3 PDE (c
GMP-inhibited: CGI-PDE), milrinone and cilostamide. In contrast, treat
ment with an inhibitor for type 4 PDE (cAMP-specific), rolipram, was i
neffective. These findings suggest that the oocyte expresses type 3 bu
t not type 4 PDE and that increases in intraoocyte cAMP suppress GVBD.
This hypothesis was confirmed by in situ hybridization studies with P
DE3 and PDE4 probes. PDE3B mRNA was concentrated in oocytes while PDE4
D was mainly expressed in granulosa cells. In cultured follicles, LH t
reatment induced oocyte maturation but the gonadotropin action was blo
cked by inhibitors of type 3 but not the type 4 PDE inhibitors. Furthe
rmore, treatment with the type 4, but not the type 3, PDE inhibitor mi
mics the action of LH and induces oocyte maturation, presumably by inc
reasing cAMP levels in granulosa cells. Our findings indicate that PDE
subtypes 4 and 3 are located in follicle somatic and germ cells, resp
ectively. Preferential inhibition of PDE 3 in the oocyte may lead to a
delay in oocyte maturation without affecting the cAMP-induced ovulato
ry process in the somatic cells. Conversely, selective suppression of
granulosa cell cAMP-PDE may enhance the gonadotropin induction of ovul
ation and oocyte maturation. Thus, in addition to the well-recognized
differential expression and regulation of adenylate cyclase in the som
atic and germ cell compartments of the follicle, we suggest that selec
tive regulation and expression of PDEs may be involved in the regulati
on of cAMP levels and control of oocyte maturation in the preovulatory
mammalian follicle. (C) 1996 Academic Press, Inc.